Regenerative orthopedics may improve pain and discomfort of the musculoskeletal system and enhance the healing of orthopedic conditions, such as injuries of a tendon, ligament, bone, muscle, spinal disc, meniscus of the knee, cartilage or other musculoskeletal tissue. Growing technological advancements, the prevalence of arthritis and other orthopedic conditions, orthopedic surgeries, and R&D activities are some of the key drivers of this market.
This report contains market size and forecasts of Orthopedic Regenerative Surgical Products in Global, including the following market information:
Global Orthopedic Regenerative Surgical Products Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Orthopedic Regenerative Surgical Products market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Allografts Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Orthopedic Regenerative Surgical Products include Anika Therapeutics, Vericel Corporation, Baxter, Zimmer Biomet, Stryker, Smith & Nephew, AlloSource, Amniox Medical and VSY Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Orthopedic Regenerative Surgical Products companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Orthopedic Regenerative Surgical Products Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Orthopedic Regenerative Surgical Products Market Segment Percentages, by Type, 2021 (%)
Allografts
Synthetic
Cell-based
Viscosupplements
Global Orthopedic Regenerative Surgical Products Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Orthopedic Regenerative Surgical Products Market Segment Percentages, by Application, 2021 (%)
Orthopedic Pain Management
Trauma Repair
Cartilage & tendon repair
Joint reconstruction
Others
Global Orthopedic Regenerative Surgical Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Orthopedic Regenerative Surgical Products Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Orthopedic Regenerative Surgical Products revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Orthopedic Regenerative Surgical Products revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Anika Therapeutics
Vericel Corporation
Baxter
Zimmer Biomet
Stryker
Smith & Nephew
AlloSource
Amniox Medical
VSY Biotechnology
Aptissen
MiMedx